Stay updated on Omalizumab in CRSwNP: Extension Study Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.

Latest updates to the Omalizumab in CRSwNP: Extension Study Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a new revision tag, v3.7.0, indicating an update to the page's versioning metadata. The previous revision, v3.6.6, has been removed.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedUpdated the page revision label from v3.6.5 to v3.6.6, indicating a new revision of the document. This change does not modify the study content or user-facing information.SummaryDifference0.0%

- Check24 days agoChange DetectedAdds the NIH grant/contract annotation to the study's identifiers, placed with the EudraCT number. This reflects NIH funding associated with the trial.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor version update to the page documentation.SummaryDifference0.0%

- Check53 days agoChange DetectedThe Ukraine site entry is updated to Zaporizhzhya, Polissya Okruha, Ukraine, 69032, and the page revision label is updated to v3.6.4.SummaryDifference0.1%

- Check60 days agoChange DetectedPublications section updated with a new citation for Meltzer EO et al. (2024) 'Omalizumab improves sleep and health status...' in Int Forum Allergy Rhinol, adding a peer‑reviewed reference to the study's findings.SummaryDifference0.0%

Stay in the know with updates to Omalizumab in CRSwNP: Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.